FDA Investigator Patricia D Stahnke

Patricia D Stahnke has inspections in 4 countries as of 08 Jun 2023. Patricia D Stahnke has collaborated with a combinined 1573 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
9
Last Inspection Date:
08 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Italy, United Kingdom of Great Britain and Northern Ireland, Belgium
Co-Investigator(s):
Alan P Kurtzberg, Anastasia G Lolas, Anissa M Cheung, Brenda W Uratani, PhD, Brooke K Higgins, Bryce A Hammer, Burnell M Henry, Caroline H Le, Catherine J Laufmann, Cheryl A Clausen, Christine L Williams, David A Gonzalez, David J Gomes, David M Beltran, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Edith M Gonzalez, Edwin Melendez, Elizabeth D Gonzales, Erika V Butler, Felix Maldonado, Genoula K Ryan, Gerald B Seaborn, Jr, Ginger M Sykes, Gwyn G Dickinson, Haroon Vohra (NMI), Helen B Ricalde, Isabel Y Espinosa, Ivis Lnegron Torres, James C Maclaughlin, Jamie L Dion, Jonathan R Campos, Julie D Bringger, Justin A Boyd, Kathy Lee, Kevin A Gonzalez, Kham Phommachanh, Kimberley A Hoefen, Larisa E Pavlick, Larry K Austin, Laura Fontan, MS, Lewis K Antwi, Libia M Lugo, Linda F Murphy, Linda M Cheny, Marcus F Yambot, Margarita Santiago, Marion Michaelis, Marvin D Jones, Mary E Farbman, PhD, Matthew R Dionne, Megan A Haggerty, Michael E Maselli, Michael R Goga, Mihaly S Ligmond, Mra Davism, Mra Mcculloughj, Mra Munizn, Nancy G Schmidt, Omotunde O Osunsanmi, Pal S Mayasandra, Patricia A Maestas, Paul L Figarole, Jr, Ravichandran Veerasamy, Rebecca E Dombrowski, Regina T Brown, Robert J Burger, Rose Xu, Rowena S Nguyen, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Satheesh Thomas, Sharon K Thoma, PharmD, Sixto M Mercado Rios, State Agency, Stephen D Brown, Steven C Madzo, Steven P Donald, Susan M Jackson, Susant Hadman, Tamara L Setzer, Tammara A Stephens, Theressa B Smith, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD, Zhongren Wu

Patricia D Stahnke's Documents

Publish Date Document Type Title
July, 2014 FDA 483 FUJIFILM Diosynth Biotechnologies UK Ltd - Form 483, 2014-07-11
July, 2015 FDA 483 SmithKline Beecham Ltd - Form 483, 2015-07-10
December, 2009 FDA 483 TOLMAR INC - Form 483, 2009-12-11
June, 2015 FDA 483 Pfizer Manufacturing Belgium NV - Form 483, 2015-06-30

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more